292
Views
8
CrossRef citations to date
0
Altmetric
Review Articles

Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors

, , , , &
Pages 562-569 | Received 15 Sep 2019, Accepted 23 Oct 2019, Published online: 13 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria V Deligiorgi & Dimitrios T Trafalis. (2023) Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer. Personalized Medicine 20:1, pages 87-105.
Read now

Articles from other publishers (6)

Zhipeng Wang, Hongsen Wang, Chen Bu, Bosu Meng, Yuhui Mu, Shouhong Gao, Wansheng Chen & Xia Tao. (2024) Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications. European Journal of Clinical Pharmacology 80:6, pages 827-838.
Crossref
Cornelia S Link-Rachner, Andy Göbel, Nikolai P Jaschke & Tilman D Rachner. (2024) Endocrine health in survivors of adult-onset cancer. The Lancet Diabetes & Endocrinology 12:5, pages 350-364.
Crossref
Layal Chaker, David S Cooper, John P Walsh & Robin P Peeters. (2024) Hyperthyroidism. The Lancet 403:10428, pages 768-780.
Crossref
Mônica R. Gadelha, Luiz Eduardo Wildemberg & Leandro Kasuki. 2022. The Pituitary. The Pituitary 413 427 .
Xiaolan Liao, Zhihong Liu & Hongtao Song. (2021) Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real‐world study based on FAERS. Journal of Clinical Pharmacy and Therapeutics 46:5, pages 1418-1425.
Crossref
Giulia Puliani & Marialuisa Appetecchia. (2021) Endocrine Toxicities of Antineoplastic Therapy. Cancers 13:2, pages 294.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.